tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Orchestra Biomed Holdings Inc

OBIO
Add to Watchlist
5.950USD
+0.020+0.34%
Close 09-24 16:00（ET）
356.29MMarket Cap
LossP/E TTM

Orchestra Biomed Holdings Inc

5.950
+0.020+0.34%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

OBIO Financials

See Orchestra Biomed Holdings Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
356.29M
Dividend TTM
0.00
P/E TTM
-6.26
EPS TTM
-0.95
Revenue
33.48M
Net Profit
-61.02M
ROE
-189.00%
ROA
-68.33%

Orchestra Biomed Holdings Inc Earnings Date

Latest Release
Aug 10, 2026
EPS / Forecast
-0.38/-0.39
Revenue / Forecast
88.00K/121.40K

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
25.18%-0.38
32.86%-0.33
122.78%0.10
2.66%-0.40
-12.99%-0.50
-30.35%-0.49
-16.36%-0.42
-8.52%-0.41
-28.26%-0.45
4.92%-0.38
-18.34%-0.36
---0.38
---0.35
---0.40
---0.31
---0.82
----
----
----
----
Revenue
-89.47%88.00K
-87.33%110.00K
12120.16%30.92M
-12.77%861.00K
7.46%836.00K
40.00%868.00K
-3.44%253.00K
135.56%987.00K
-14.97%778.00K
-46.74%620.00K
-76.25%262.00K
-63.97%419.00K
128.18%915.00K
34.41%1.16M
144.97%1.10M
-12.75%1.16M
141.00%401.00K
-34.19%866.00K
---2.45M
--1.33M
Net Profit
-24.36%-24.08M
-10.14%-20.66M
137.08%5.99M
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.75M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-20.89%-9.75M
-95.59%-10.28M
-27.49%-7.85M
-61.97%-5.73M
---8.06M
---5.26M
Net Margin
-1065.48%-26994.32%
-767.60%-18746.36%
100.32%20.20%
-54.78%-2419.05%
-12.76%-2316.15%
0.49%-2160.71%
-30.52%-6385.38%
50.82%-1562.92%
-56.02%-2053.98%
-131.04%-2171.45%
-453.46%-4892.37%
---3178.04%
---1316.50%
---939.86%
---883.95%
---981.81%
----
----
----
----
Gross Margin
-24.24%71.59%
-25.30%70.91%
29.53%99.84%
1.29%94.31%
0.16%94.50%
0.44%94.93%
-6.08%77.08%
3.21%93.11%
0.26%94.34%
-1.77%94.52%
-13.80%82.06%
--90.21%
--94.10%
--96.22%
--95.19%
--93.50%
----
----
----
----
Debt to assets ratio
-10.35%30.11%
-41.36%14.24%
-33.79%12.42%
--13.55%
--33.59%
--24.28%
--18.76%
----
----
----
-100.00%0.00%
--8.25%
--7.60%
--6.99%
--9.93%
--8.72%
----
----
----
----
Income Statement
Revenue
-89.47%88.00K
-87.33%110.00K
12120.16%30.92M
-12.77%861.00K
7.46%836.00K
40.00%868.00K
-3.44%253.00K
135.56%987.00K
-14.97%778.00K
-46.74%620.00K
-76.25%262.00K
-63.97%419.00K
128.18%915.00K
34.41%1.16M
144.97%1.10M
-12.75%1.16M
141.00%401.00K
-34.19%866.00K
---2.45M
--1.33M
Operating profit
-15.67%-22.36M
-16.67%-22.08M
140.50%6.75M
-24.30%-20.31M
-14.64%-19.33M
-31.19%-18.92M
-33.62%-16.68M
-12.52%-16.34M
-30.13%-16.86M
-24.93%-14.42M
-26.99%-12.48M
-44.27%-14.52M
-69.71%-12.96M
-125.14%-11.54M
-24.29%-9.83M
-129.47%-10.07M
-36.71%-7.63M
-30.78%-5.13M
---7.91M
---4.39M
Net Profit
-24.36%-24.08M
-10.14%-20.66M
137.08%5.99M
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.75M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-20.89%-9.75M
-95.59%-10.28M
-27.49%-7.85M
-61.97%-5.73M
---8.06M
---5.26M
Balance Sheet
Current assets
210.02%111.24M
85.36%96.21M
56.01%107.91M
42.62%97.77M
-46.03%35.88M
-32.09%51.90M
-22.38%69.17M
-37.79%68.55M
-44.41%66.48M
-41.15%76.43M
5.22%89.11M
11.87%110.19M
10.12%119.59M
326.54%129.88M
--84.69M
--98.50M
--108.60M
--30.45M
----
----
Total current liabilities
-21.04%13.47M
-11.60%13.69M
3.26%16.74M
27.36%20.66M
17.63%17.06M
48.70%15.49M
44.60%16.21M
-24.47%16.22M
22.29%14.50M
-13.61%10.42M
-39.63%11.21M
6.66%21.47M
-39.79%11.86M
-7.14%12.06M
--18.57M
--20.13M
--19.70M
--12.98M
----
----
Total assets
170.17%115.70M
70.46%100.66M
50.78%114.86M
39.15%104.81M
-40.84%42.83M
-28.53%59.05M
-20.00%76.17M
-35.27%75.32M
-42.50%72.38M
-39.37%82.63M
-0.38%95.21M
7.39%116.36M
7.49%125.88M
285.00%136.28M
--95.57M
--108.35M
--117.11M
--35.40M
----
----
Total liabilities
102.87%86.28M
17.77%49.69M
19.12%51.48M
109.86%61.07M
50.51%42.53M
65.86%42.19M
59.06%43.22M
-20.71%29.10M
-22.46%28.26M
-30.35%25.44M
-36.87%27.17M
-21.78%36.70M
-23.45%36.44M
3.42%36.53M
--43.04M
--46.92M
--47.61M
--35.32M
----
----
Total equity
9872.88%29.42M
202.34%50.97M
92.30%63.38M
-5.37%43.74M
-99.33%295.00K
-70.52%16.86M
-51.56%32.96M
-41.98%46.22M
-50.66%44.13M
-42.67%57.19M
29.52%68.04M
29.67%79.66M
28.68%89.44M
127788.46%99.75M
--52.53M
--61.43M
--69.51M
--78.00K
----
----
Cash Flow Statement
Net operating income
-24.51%-19.33M
-33.41%-22.17M
83.23%-2.27M
-6.20%-14.55M
-52.14%-15.53M
-26.70%-16.62M
-23.36%-13.54M
-33.24%-13.70M
2.71%-10.21M
8.81%-13.11M
-25.50%-10.97M
-41.70%-10.28M
-31.70%-10.49M
-170.12%-14.38M
-89.88%-8.74M
-50.29%-7.26M
-80.61%-7.96M
4.69%-5.32M
---4.61M
---4.83M
Net investment
-242.51%-23.31M
-20.62%10.32M
-371.94%-17.71M
-7027.11%-38.58M
56.91%16.36M
121.79%13.00M
-111.32%-3.75M
-95.70%557.00K
28.41%10.42M
113.46%5.86M
152.31%33.15M
5879.91%12.95M
1812.66%8.12M
-92514.89%-43.53M
-18706.23%-63.38M
-103.57%-224.00K
-107.48%-474.00K
-106.33%-47.00K
---337.00K
--6.28M
Net financing
8218.22%34.75M
1967.23%5.53M
-9.23%12.66M
408.13%76.40M
-350.29%-428.00K
-1744.44%-296.00K
230.39%13.95M
375775.00%15.04M
98.84%171.00K
-99.97%18.00K
-110.14%-10.70M
100.16%4.00K
-99.90%86.00K
129.45%56.82M
-412.59%-5.09M
-149.80%-2.50M
8708.10%86.08M
2576.40%24.76M
---993.00K
---1.00M

FAQs

What is the total revenue of Orchestra Biomed Holdings Inc?

According to Orchestra Biomed Holdings Inc's FY2025 earnings report, its total revenue reached 33.48M, with a year-on-year change of 2.64M.

What are the current assets of Orchestra Biomed Holdings Inc?

According to Orchestra Biomed Holdings Inc's FY2025 earnings report, its current assets were 107.91M, with a year-on-year change of 56.01.

What are the total assets of Orchestra Biomed Holdings Inc?

According to Orchestra Biomed Holdings Inc's FY2025 earnings report, its total assets of Orchestra Biomed Holdings Inc were 114.86M, with a year-on-year change of 50.78.

What are the total liabilities of Orchestra Biomed Holdings Inc?

According to Orchestra Biomed Holdings Inc's FY2025 earnings report, its total liabilities of Orchestra Biomed Holdings Inc were 51.48M, with a year-on-year change of 19.12.

What is the total equity of Orchestra Biomed Holdings Inc?

According to Orchestra Biomed Holdings Inc's FY2025 earnings report, its total equity of Orchestra Biomed Holdings Inc was 63.38M, with a year-on-year change of 92.30.

What is the net operating income of Orchestra Biomed Holdings Inc?

According to Orchestra Biomed Holdings Inc's FY2025 earnings report, its net operating income of Orchestra Biomed Holdings Inc was -51.81M, with a year-on-year change of 19.43.

What is the net investment of Orchestra Biomed Holdings Inc?

According to Orchestra Biomed Holdings Inc's FY2025 earnings report, its net investment of Orchestra Biomed Holdings Inc was -26.94M, with a year-on-year change of -305.83.

What is the net financing of Orchestra Biomed Holdings Inc?

According to Orchestra Biomed Holdings Inc's FY2025 earnings report, its net financing of Orchestra Biomed Holdings Inc was 88.33M, with a year-on-year change of 202.81.

What is the Earnings Per Share (EPS) of Orchestra Biomed Holdings Inc?

According to Orchestra Biomed Holdings Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.11, with a year-on-year change of 33.08.

What is the net income of Orchestra Biomed Holdings Inc?

According to Orchestra Biomed Holdings Inc's FY2025 earnings report, its net income was -52.95M, with a year-on-year change of 13.22.

What is the net margin of Orchestra Biomed Holdings Inc?

According to Orchestra Biomed Holdings Inc's FY2025 earnings report, its net profit margin was -157.40, with a year-on-year change of 93.20.

What is the gross margin of Orchestra Biomed Holdings Inc?

According to Orchestra Biomed Holdings Inc's FY2025 earnings report, its gross margin was 99.43, with a year-on-year change of 7.77.

What is the debt-to-asset ratio of Orchestra Biomed Holdings Inc?

According to Orchestra Biomed Holdings Inc's FY2025 earnings report, its debt-to-asset ratio was 12.42, with a year-on-year change of -33.79.

What is the Return on Equity (ROE) of Orchestra Biomed Holdings Inc?

According to Orchestra Biomed Holdings Inc's FY2025 earnings report, its Return on Equity (ROE) was -122.40, with a year-on-year change of -1.29.

What is the Return on Assets (ROA) of Orchestra Biomed Holdings Inc?

According to Orchestra Biomed Holdings Inc's FY2025 earnings report, its Return on Assets (ROA) was -55.18, with a year-on-year change of 22.52.

What is the operating profit of Orchestra Biomed Holdings Inc?

According to Orchestra Biomed Holdings Inc's FY2025 earnings report, its operating profit was -51.81M, with a year-on-year change of 19.43.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy